ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2005

Influenza treatment with neuraminidase inhibitors: cost-effectiveness and cost-utility in healthy adults in the United Kingdom.

Beate Sander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.